Civil Plaintiff

Heart Drug Valsartan Tainted With Carcinogens Faces a Wave of Lawsuits

Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation.

“My best estimate sitting here today is I expect that we will have approximately 2,000 personal-injury cases on file in the next two years,” Daniel Nigh, who has filed 12 such lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month, according to a transcript.

Read the source article at msn.com

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button